0001209191-19-035908.txt : 20190610 0001209191-19-035908.hdr.sgml : 20190610 20190610173751 ACCESSION NUMBER: 0001209191-19-035908 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190601 FILED AS OF DATE: 20190610 DATE AS OF CHANGE: 20190610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassidy Meghan CENTRAL INDEX KEY: 0001775175 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38710 FILM NUMBER: 19889440 MAIL ADDRESS: STREET 1: C/O CORTEVA, INC. STREET 2: 974 CENTRE ROAD, BLDG. 735 CITY: WILMINGTON STATE: DE ZIP: 19805 FORMER NAME: FORMER CONFORMED NAME: CASSIDY MEHGAN DATE OF NAME CHANGE: 20190429 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corteva, Inc. CENTRAL INDEX KEY: 0001755672 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 824979096 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 BUSINESS PHONE: (302) 485-3000 MAIL ADDRESS: STREET 1: 974 CENTRE ROAD STREET 2: BUILDING 735 CITY: WILMINGTON STATE: DE ZIP: 19805 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-06-01 0 0001755672 Corteva, Inc. CTVA 0001775175 Cassidy Meghan C/O CORTEVA, INC. 974 CENTRE ROAD, CRP 735 WILMINGTON DE 19805 0 1 0 0 See Remarks Common Stock 26342.3236 D Non-Qualified Stock Options 26.76 2026-02-02 Common Stock 19673 D Non-Qualified Stock Options 34.68 2027-02-01 Common Stock 19792 D Non-Qualified Stock Options 41.94 2028-02-14 Common Stock 8624 D On June 1, 2019, the Reporting Person received a dividend of one (1) share of Corteva, Inc. common stock for every three (3) shares of DowDuPont Inc. held by the Reporting Person, and the Reporting Person's equity awards denominated in DowDuPont common stock were adjusted, in part, into equity awards denominated in Corteva common stock, all as described in Corteva's Registration Statement on Form 10 filed with the Securities and Exchange Commission on May 6, 2019. This amount includes restricted stock units and related dividend equivalent units. In connection with the separation, certain outstanding DowDuPont stock options were converted into awards of options to purchase shares of the Issuer's common stock. The number of shares and exercise prices of each option award were adjusted in a manner intended to preserve the economic/intrinsic value of the original DowDuPont stock option. This option is fully vested and exercisable. 13,194 options are vested and exercisable. The remaining options will vest on February 2, 2020. 2,874 options are vested and exercisable. The remaining options will vest in two equal installments on February 15, 2020 and February 15, 2021. Senior Vice President, Chief Human Resources Officer /s/Robert Hahm, attorney-in-fact 2019-06-10 EX-24.3_858933 2 poa.txt POA DOCUMENT POWER OF ATTORNEY The undersigned hereby constitutes and appoints each of Cornel Fuerer, Robert Hahm and Abigail Jarrell, or either of them acting singly and with full power of substitution, as the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Corteva, Inc. (the "Company"), Forms 3, 4, and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended the "Exchange Act"), and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the "SEC") and any securities exchange or similar authority, including without limitation the execution and filing of a Form ID or any other documents necessary or appropriate to obtain codes and passwords to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC; and (3) take any other action in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of beneift to, in the best interest of, or legally required by or for, the undersigned, it being understood that the documents executed by such attorney- in-fact on behalf of the undersigned pursuant to this power of attorney shall be in such form and shall contain such information and disclosure as such attorney-in-fact may approve in such attorney- in-fact's discretion. The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with any provision of Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 17th day of April, 2019. Signed and acknowledged: /s/ Meghan Cassidy -------------------------------------- Meghan Cassidy